This systematic review and meta-analysis of RCTs found that use of GLP-1 RAs was associated with increased risk of gallbladder or biliary diseases, especially when used at higher doses, for longer durations, and for weight loss (JAMA Internal Medicine)
Diabetes News
Tag: gallbladder
Association of Bile Duct and Gallbladder Diseases With the Use of Incretin-Based Drugs in Patients With Type 2 Diabetes Mellitus
The use of GLP-1 analogues was associated with an increased ri sk of bile duct and gallbladder disease. Physicians should be aware of this potential adverse event when prescribing these drugs (JAMA Internal Medicine)
Glycosmedia is also available as an App: